The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly
Abstract
Object. The results of surgical therapy for acromegaly were assessed using carefully conducted endocrinological testing in 115 patients who underwent transsphenoidal surgery from 1981 to 1995. Methods. Ninety-nine of the 115 patients could be contacted for follow-up review; in 57 of the patients an endocrinological assessment was performed by the authors. Biochemical cure was strictly defined as a normalization of the insulin-like growth factor(IGF)—I level (obtained in 100 patients) and/or a basal or glucose-suppressed growth hormone (GH) level of 2 ng/ml or less. The mean length of follow up from transsphenoidal surgery to laboratory testing was 5.4 years with a maximum of 15.7 years. After transsphenoidal surgery alone, 61% of the patients achieved a biochemical remission; the remission rate was 88% for patients with microadenomas and 53% for those with macroadenomas. Tumor size and preoperative GH level tended to correlate negatively with outcome of surgery. Early postoperative GH level tended to correlate with long-term outcome; in cases in which the early postoperative GH level was lower than 3 ng/ml, the chance of long-term remission was 89%. Thirty-two patients received postoperative radiotherapy: in 10 (31%) of these patients the disease is currently in remission after surgery and radiotherapy only and in three others the disease is in remission with the addition of medical therapy. The overall complication rate was 6.9% with no cerebrospinal fluid leaks, meningitis, permanent diabetes insipidus, or new hypopituitarism. The overall recurrence rate was low at 5.4%. Conclusions. This series shows, based on IFGF—I measurements and strict GH supression criteria to define remission, that transsphenoidal surgery provides an excellent chance for long-term cure in patients with microadenomas. Surgery alone is successful in most patients with noninvasive macroadenomas; however, most patients with invasive macroadenomas will require adjunctive therapy. Recurrences are uncommon when biochemical remission is clearly documented postoperatively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C
Clemmons, D. R., Van Wyk, J. J., Ridgway, E. C., Kliman, B., Kjellberg, R. N., & Underwood, L. E. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911223012102 · Cited by 364
Frantz, A. G., & Rabkin, M. T. (1964) · New England Journal of Medicine · doi:10.1056/nejm196412312712701 · Cited by 283
Ross, D. A., & Wilson, C. B. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.6.0854 · Cited by 260
Conventional Supervoltage Irradiation Is an Effective Treatment for Acromegaly
EASTMAN, R. C., GORDEN, P., & ROTH, J. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-6-931 · Cited by 241
BARKAN, A. L., BEITINS, I. Z., & KELCH, R. P. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-1-69 · Cited by 239
Treatment of Acromegaly with Dopamine Agonists
Jaffe, C. A., & Barkan, A. L. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30210-x · Cited by 220
Surgical Management of Acromegaly
Fahlbusch, R., Honegger, J., & Buchfelder, M. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30208-1 · Cited by 201
Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure
Sheaves, R., Jenkins, P., Blackburn, P., Huneidi, A. H., Afshar, F., Medbak, S., Grossman, A. B., Besser, G. M., & Wass, J. A. H. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8370847.x · Cited by 199
Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly
Melmed, S. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3395 · Cited by 196
Chapman, I. M. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.6.1312 · Cited by 194
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Criteria for Cure of Acromegaly: A Consensus Statement
Giustina, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.526 · Cited by 987
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Self-citationLong-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
van der Lely, A. J., Hutson, R. K., Trainer, P. J., Besser, G. M., Barkan, A. L., Katznelson, L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M. L., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06844-1 · Cited by 645
Self-citationThe outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’
Nomikos, P., Buchfelder, M., & Fahlbusch, R. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01863 · Cited by 500
Dehdashti, A. R., Ganna, A., Karabatsou, K., & Gentili, F. (2008) · Neurosurgery · doi:10.1227/01.neu.0000297072.75304.89 · Cited by 408
Endoscopic pituitary surgery: a systematic review and meta-analysis: Clinical article
Tabaee, A., Anand, V. K., Barrón, Y., Hiltzik, D. H., Brown, S. M., Kacker, A., Mazumdar, M., & Schwartz, T. H. (2009) · Journal of Neurosurgery · doi:10.3171/2007.12.17635 · Cited by 363
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
Kopchick, J. J., Parkinson, C., Stevens, E. C., & Trainer, P. J. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0022 · Cited by 352
Roelfsema, F., Biermasz, N. R., & Pereira, A. M. (2012) · Pituitary · doi:10.1007/s11102-011-0347-7 · Cited by 346
Guidelines for Acromegaly Management
Melmed, S., Casanueva, F. F., Cavagnini, F., Chanson, P., Frohman, L., Grossman, A., Ho, K., Kleinberg, D., Lamberts, S., Laws, E., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-011841 · Cited by 343
Kreutzer, J., Vance, M. L., Lopes, M. B. S., & Laws, E. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4072 · Cited by 341
Late Recurrences of Cushing’s Disease after Initial Successful Transsphenoidal Surgery
Patil, C. G., Prevedello, D. M., Lad, S. P., Vance, M. L., Thorner, M. O., Katznelson, L., & Laws, E. R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2013 · Cited by 320
Jane, J. A., Starke, R. M., Elzoghby, M. A., Reames, D. L., Payne, S. C., Thorner, M. O., Marshall, J. C., Laws, E. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0554 · Cited by 316
Results of Transsphenoidal Surgery in a Large Series of Patients with Pituitary Adenoma
Mortini, P., Losa, M., Barzaghi, R., Boari, N., & Giovanelli, M. (2005) · Neurosurgery · doi:10.1227/01.neu.0000159647.64275.9d · Cited by 305
Zada, G., Kelly, D. F., Cohan, P., Wang, C., & Swerdloff, R. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.2.0350 · Cited by 302
Somatostatin Analogs in Acromegaly
Freda, P. U. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3013 · Cited by 298
Self-citation(2011) · Endocrine Practice · doi:10.4158/ep.17.s4.1 · Cited by 259
Zada, G., Sivakumar, W., Fishback, D., Singer, P. A., & Weiss, M. H. (2010) · Journal of Neurosurgery · doi:10.3171/2009.7.jns09438 · Cited by 25
Clinical predictors of GH deficiency in surgically cured acromegalic patients
Ku, C. R., Hong, J. W., Kim, E. H., Kim, S. H., & Lee, E. J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0304 · Cited by 24
Metadata
- Authors
- Freda, P. U., Wardlaw, S. L., & Post, K. D.
- Venue
- Journal of Neurosurgery
- Published
- 1998-09
- Volume
- 89
- Issue
- 3
- Pages
- 353-358
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2031639107
- Cited by
- 281
- References
- 12
- FWCI
- 10.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.